Sirenomelia after phenobarbital and carbamazepine therapy in pregnancy

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 97, Issue 6, 2013, Pages 425-428

  Tica, Oana Sorina ^a,b   Tica, Andrei Adrian ^a,b   Brailoiu, Cristina Gabriela ^c   Cernea, Nicolae ^a,b   Tica, Vlad Iustin ^d,e  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b Emergency Hospital   (Romania)

^c Jefferson School of Pharmacy   (United States)

^d OVIDIUS UNIVERSITY   (Romania)

^e UnivRegEmergency Hospital   (Romania)

Author keywords

Carbamazepine; Caudal dysgenesis; Epilepsy; Phenobarbital; Sirenomelia

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL;

ANTICONVULSANT THERAPY; ANUS ATRESIA; ARTICLE; BLADDER MALFORMATION; BONE MALFORMATION; DELIVERY; DRUG POTENTIATION; DRUG WITHDRAWAL; EAR MALFORMATION; FEMALE; FETUS MALFORMATION; FINGER MALFORMATION; FOCAL EPILEPSY; FOOT MALFORMATION; GENITAL MALFORMATION; HIGH RISK PREGNANCY; HUMAN; HYPOPLASIA; KIDNEY AGENESIS; NAIL HYPOPLASIA; NOSE MALFORMATION; OLIGOHYDRAMNIOS; PALPEBRAL FISSURE ANOMALY; PREGNANCY; PRIORITY JOURNAL; PROGNATHIA; RECTUM DISEASE; SINGLE UMBILICAL ARTERY; SIRENOMELIA; STILLBIRTH; TERATOGENICITY; UTERUS MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; CARBAMAZEPINE; ECTROMELIA; EPILEPSY; FATAL OUTCOME; FEMALE; HUMANS; PHENOBARBITAL; PREGNANCY;

EID: 84879782938     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23132     Document Type: Article

References (33)

1. Boréus LO, Jalling B, Kållberg N. 1978. Phenobarbital metabolism in adults and in newborn infants. Acta Paediatr Scand 67:193-200.
2. Buehler BA, Delimont D, van Waes M, Finnell RH. 1990. Prenatal prediction of risk of the fetal hydantoinic syndrome. N Engl J Med 322:1567-1572.
3. Cantrell DC, Cunningham FG. 1994. Epilepsy complicating pregnancy. Supplement to Williams obstetrics. 19th ed. Stamford, CT: Appleton & Lange.
4. Chandebois R, Brunet C. 1987. Origin of abnormality in a human simelian foetus as elucidated by our knowledge of vertebrate development. Teratology 36:11-22.
5. Colby RS. 2005. Sirenomelia. In: Narins B, editor. Gale encyclopedia of genetic disorders, Part II. Thomson Gale: Farmington Hills. p 1191-1194.
6. Contu R, Zoppi MA, Axiana C, et al. 2009. First trimester diagnosis of sirenomelia by 2D and 3D ultrasound. Fetal Diagn Ther 26:41-44.
7. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC III, Hauth JC, Wenstrom KD. 2001. Neurological and psychiatric disorders. In: Cunningham FG, Whitridge J, editors. Williams Obstetrics, 21st ed. New York: McGraw-Hill. p 1407-1409.
8. Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. 2001. Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology 57:321-324.
9. Duesterhoeft SM, Ernst LM, Siebert JR, Kapur RP. 2007. Five cases of caudal regression with an aberrant abdominal umbilical artery: further support for a caudal regression-sirenomelia spectrum. Am J Med Genet A 143:3175-3184.
10. Eisenschenk S. 2006. Treatment with oxcarbazepine during pregnancy. Neurologist 12:249-254.
11. Finnell RH, Bennett GD, Slattery JT, et al. 1995. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation. Teratology 52:324-332.
12. Flockhart DA. 2007. Drug Interactions: Cytochrome P450 Drug Interaction Table. Indiana University School of Medicine. http://medicine.iupui.edu/clinpharm/ddis/table.aspx. Accessed November 18, 2012.
13. Fretland AJ, Omiecinski CJ. 2000. Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact 129:41-59.
14. Heinonen OP, Slone D, Shapiro S. 1977. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group. p 441-453.
15. Holmes LB, Harvey EA, Coull BA, et al. 2001. The teratogenicity of anticonvulsant drugs. N Engl J Med 344:1132-1138.
16. Horning MG, Stratton C, Wilson A, et al. 1974. Detection of 5-(3, 4)-diphenylhydantoin in new born human. Anal Lett 4:537-582.
17. Johnson TN, Tucker GT, Rostami-Hodjegan A. 2008. Development of CYP2D6 and CYP3A4 in the first year of life. Clin Pharmacol Ther 83:670-671.
18. Jones KL, Lacro RV, Jonson KA, Adams J. 1989. Patterns of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320:1661-1666.
19. Källén B, Castilla EE, Lancaster PA, et al. 1992. The cyclops and the mermaid: an epidemiological study of two types of rare malformation. J Med Genet 29:30-35.
20. Koren G. 2001. Special aspects of perinatal & pediatric pharmacology. In: Katzung BG, editor. Basic & clinical pharmacology. New York: McGraw-Hill. p 1025-1035.
21. Kwan P, Brodie MJ. 2004. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 45:1141-1149.
22. Lopez-Valdez JA, Estrada-Juarez H, Moreno-Verduzco ER, Aguinaga-Rios M. 2013. A fetus with hemifacial microsomia and sirenomelia. The same mesodermal defect spectrum? Fetal Pediatr Pathol 32:152-157.
23. Matalon S, Schechtman S, Goldzweig G, Ornoy A. 2003. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 16:9-17.
24. McNamura JO. 1996. Drugs effective in the therapy of epilepsies. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, editors. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill. p 471-475.
25. Nelson KB, Ellenberg JH. 1982. Maternal seizure disorders, outcome of pregnancy, and neurologic abnormalities in the children. Neurology 32:1247-1254.
26. Olfsson E, Hallgrimsson JT, Hauser WA, et al. 1988. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 39:887-892.
27. Reinish JM, Sanders SA, Mortensen EL, Rubin DB. 1992. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274:1518-1525.
28. Spina E, Martines C, Fazio A, et al. 1991. Effect of phenobarbital on the pharmacokinetic of carbamazepine-10, 11-epoxide, an active metabolite of carbamazepine. Ther Drug Monit 13:109-112.
29. Stocker JT, Heifetz SA. 1987. Sirenomelia. A morphological study of 33 cases and review of the literature. Perspect Pediatr Pathol 10:7-50.
30. Tang BK, Yilmaz B, Kalow K. 1984. Determination of phenobarbital, p-hydroxy-phenobarbital and phenobarbital-N-glucoside in urine by gas chromatography chemical ionization mass spectrometry. Biol Mass Spectrom 11:462-465.
31. Tiu C. 2002. Neurological diseases and pregnancy. In: Vladareanu R, editor. Medical diseases associated with pregnancy. Bucharest: Infomedica. p 352-371.
32. Vestermark V, Vestermark S. 1991. Teratogenic effect of carbamazepine. Arch Dis Child 66:641-642.
33. Yerby MS. 1993. Epilepsy and pregnancy. New issues for an old disorder. Neurol Clin 11:777-786.